APA (7th ed.) Citation

S, M., EY, I., RL, R., LM, F., K, B., M, L., & BE, E. (2026). Blood-based proteomic profiling reveals context-dependent changes in BCL2-associated signaling during taxane therapy in breast cancer patients. FEBS open bio. https://doi.org/10.1002/2211-5463.70239

Chicago Style (17th ed.) Citation

S, Munshani, Ibrahim EY, Rodwin RL, Ferrucci LM, Blenman K, Lustberg M, and Ehrlich BE. "Blood-based Proteomic Profiling Reveals Context-dependent Changes in BCL2-associated Signaling During Taxane Therapy in Breast Cancer Patients." FEBS Open Bio 2026. https://doi.org/10.1002/2211-5463.70239.

MLA (9th ed.) Citation

S, Munshani, et al. "Blood-based Proteomic Profiling Reveals Context-dependent Changes in BCL2-associated Signaling During Taxane Therapy in Breast Cancer Patients." FEBS Open Bio, 2026, https://doi.org/10.1002/2211-5463.70239.